SenzaGen AB (STO:SENZA)
Sweden · Delayed Price · Currency is SEK 4.990
-0.010 (-0.20%)
Sep 3, 2026, 9:49 AM CET
SenzaGen AB Market Cap
SenzaGen AB has a market cap or net worth of 162.54 million as of September 2, 2026. Its market cap has decreased by -10.86% in one year.
Market Cap
162.54M
Enterprise Value
143.85M
Revenue
61.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.99
ChartMarket Cap Chart
Since September 21, 2017, SenzaGen AB's market cap has decreased from 669.46M to 162.54M, a decrease of -75.72%. That is a compound annual growth rate of -14.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 162.54M | -9.39% |
| Dec 30, 2025 | 179.38M | -11.88% |
| Dec 30, 2024 | 203.58M | 15.61% |
| Dec 29, 2023 | 176.09M | -39.28% |
| Dec 30, 2022 | 289.98M | 22.62% |
| Dec 30, 2021 | 236.48M | -15.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 156.21B |
| Getinge AB | 66.43B |
| Sectra AB | 56.88B |
| Medicover AB | 36.85B |
| Promimic AB | 171.92M |
| Abera Bioscience AB | 163.17M |
| Alzinova AB | 162.11M |
| Scandinavian Real Heart AB (Publ) | 161.03M |